Although NF2 primarily involves benign tumors, the condition is closely related to the field of oncology due to the potential for these tumors to cause serious complications. Additionally, patients with NF2 have an increased risk of developing other types of tumors, including meningiomas and spinal cord ependymomas. Understanding the tumor biology in NF2 can also provide insights into cancer mechanisms and therapies.
